Posts Tagged With ‘ Research ’

Does it matter that there are too many residential real estate agents? Yes, says a consumer group. More than 1.5 million residential agents, including brokers, compete for home sales usually totaling 5 to 6 million annually. The plethora of real estate agents comes with costs, according to a study by the Consumer Federation of America, that include: Economic inefficiencies including an excessive amount of time spent by agents finding clients. Relatively low incomes of many full-time agents. Frustration by these agents and by many consumers who deal with inexperienced agents. Reinforcement of... Continue Reading

Photo: White House The Inflation Reduction Act, signed into law a year ago, has many benefits for American consumers. It began making big corporations pay their fair share in taxes while investing more in items that help the middle class such as creating good-paying jobs, combating corporate price gouging, slashing the deficit, lowering prescription drug costs, and reducing carbon pollution. But while these efforts are helping everyday Americans, a new review from government watchdog Accountable.US shows several industries have never stopped trying to obstruct and weaken the Inflation Reduction... Continue Reading

The Food and Drug Administration has decided that food manufacturers can keep using phthalates, a class of toxic chemicals, in food packaging and food production equipment. It disregarded requests from health and environmental advocates to reconsider that decision based on evidence that phthalates in food are harmful to health. Safer substitutes for these chemicals are available, advocates argue. “There is overwhelming evidence that phthalates in our food cause life-altering damage to people’s health, including the health of babies and young children,” said Earthjustice Attorney Katherine... Continue Reading

Recently, I wrote about how private equity firms are buying health providers practices, including my gastroenterologist’s, and how they bleed money from the companies, then sell them for a big profit. In 2021, some of the top industries for private equity investment include healthcare, technology, and consumer products.  Now, a new report describes how private equity firms buying oil and gas wells is likely to be costly for taxpayers. Investments by private equity firms in nearly 2,700 oil and gas wells on federal and tribal lands across the western United States could leave taxpayers with... Continue Reading

It’s not surprising that men are succumbing to the same advertising on looking good that has enticed women to buy for decades. The average adult man in the United States uses 11 different personal care products every day, nearly twice as many as 20 years ago, according to a survey by Morning Consult. The survey also showed that on average, women use 13 products daily, up from 12 in 2004. Combining the usage for men and women, the average adult uses 12 personal care products in a day. The 12 products could be made with as many as 112 chemicals, some of which may pose serious health risks, an... Continue Reading

Consumers with poor credit pay hundreds or even thousands of dollars more every year for basic auto insurance coverage required by state laws, new report shows. “On average, a consumer with poor credit has to pay twice as much for auto insurance as a driver with excellent credit, even if everything else, including their driving safety history, are the same,” said Douglas Heller, director of insurance for the Consumer Federation of America and the study’s co-author. The report found that nationwide, American consumers with clean driving records and excellent credit pay an average annual... Continue Reading

American companies are using unfair, deceptive, and abusive practices as they sells many consumer financial products, the Consumer Financial Protection Bureau said in a new report on what it found as it reviews business practices at financial institutions. For example, auto lenders have originated loan balances above the real value of the car being purchased and engaged in illegal collection practices while servicing these loans. The report covers findings from CFPB examinations completed from July 2022 to March 2023. “Today’s report furthers our efforts to highlight conduct that violates... Continue Reading

Many people get caught up in credit card debt. In 2022, Americans increased their credit card debt by a record $179.4 billion. The total owed by credit-card holders now is more than $1.1 trillion. However, people in some states charge less on their credit cards than others. WalletHub, a personal finance website, takes a look at the issue in “2023’s States With the Highest and Lowest Credit-Card Debts.” WalletHub found the following for median credit-card debt in the 50 states and the District of Columbia: States with the highest credit-card debts        1. Alaska – $3,517 District... Continue Reading

Another large financial institution has been caught gouging customers. Raymond James Financial Services agreed to settle allegations Tuesday with six state securities regulators for charging unreasonable commissions on trades that harmed investors. The broker-dealer will pay at least $8.2 million in refunds to clients, and $4.2 million in penalties and costs. A task force of state regulators from Alabama, California, Illinois, Massachusetts, Montana, and Washington investigated Raymond James’s compensation practices, and found that it charged excessive commissions on more than 270,000 low-principal... Continue Reading

The approval of a new drug to treat Alzheimer’s disease is controversial. The U.S. Food and Drug Administration gave full approval to the drug lecanemab (Leqembi) Thursday to treat adults with Alzheimer’s disease. In January, Public Citizen, a consumer advocacy organization, urged the agency not to approve the drug. In a letter to the FDA, it said that lecanemab investigators have concluded that longer trials are needed to determine the effectiveness and safety of lecanemab in early Alzheimer’s disease, and that three deaths thought to be related to the drug have now occurred in lecanemab... Continue Reading